Global markets mixed ahead of key central bank meetings
Iseq index advances 0.5%, dragged higher by Ryanair and the main Irish banks
Novo Nordisk
Activist hedge fund builds stake in Ozempic-maker Novo Nordisk
Parvus shows interest in Danish drugmaker that is hunting for new chief following share price slump
Should the maker of Ozempic be funding children’s playgrounds in Ireland?
In 2023, Novo Nordisk was suspended by its own industry body in the UK for two years over its sponsorship of weight management courses for health professionals
Maker of Ozempic and Wegovy broke advertising rules, regulator finds
‘Significant number of non-compliances’ by pharmaceutical firm behind weight loss drugs
Ousted Novo Nordisk CEO pays for investors’ inflated hopes
Investor expectations, it seems, are harder to manage than blood sugar
Ireland U-turns to oppose EU pharma reforms after intense lobbying
Pharmaceutical companies stepped up blitz to push Government to back industry position, lobbying logs show
Novo Nordisk ousts boss as Ozempic maker battles profit slump
Danish maker of obesity drugs to replace Lars Fruergaard Jørgensen, saying new leadership is needed
Novo Nordisk cuts sales forecasts on lower US demand for obesity drug
First-quarter sales rise 18 per cent but Danish pharma group blames custom preparations at pharmacies for weaker take-up
Novo Nordisk on the back foot ahead of earnings
Drugmaker has seen shares halved as obesity market heats up
Big pharma sees positive side effects in Trump tariffs
Industry has used trade opportunity to hand European Commission a shopping list of asks
Lilly’s weight loss pill is a ‘landmark moment’ in the obesity fight
Prof Donal O’Shea hails breakthrough and says it may play key role in reshaping treatments
Trillion-euro dream fades for slimmed-down Novo Nordisk
SAP is now Europe’s most valuable public company
Weight loss drug Wegovy to cost around €220 a month as supplies go on market in Ireland
Weight loss drug is not yet approved for reimbursement under Drug Payment Scheme or for medical card patients
Wegovy: The obesity ‘wonderdrug’ comes to Ireland, but it will cost you
Novo Nordisk’s Wegovy is about to enter the Irish market but people will have to pay for it from their own pocket - for now at least
Inside the pharma industry’s lobbying campaign to water down reforms
Pharma companies ‘disappointed’ in Government’s stance during EU negotiations
Pharma firms ‘disappointed and concerned’ by lack of State support for campaign against EU reforms
New regulations of pharma sector could cost jobs in Ireland, industry warned Government
Generic drugmaker races to launch versions of blockbuster obesity drugs
Pharma group Hikma looks to take advantage as Novo Nordisk’s Wegovy and Ozempic start to go off patent next year
Novo Nordisk to explore how obesity drugs can help patients with addiction
Danish obesity drug giant looking at whether its semaglutide drug can reduce cravings associated with addiction
Insurers will not cover obesity drugs that will cost users €2,500-plus a year
Patients looking to access Eli Lilly’s Mounjaro from next week will have to pay privately
European shares reverse declines to finish higher
Iseq index flat as Ryanair adds 1% despite sluggish traffic growth
Europe worries as Wall Street pushes ahead on benign inflation data
Indices in Europe end last full trading week with losses as Washington again battles to stop government shutdown
Novo Nordisk shares tumble as weight-loss drug trial data disappoints
Obesity drug CagriSema misses goal of 25% body weight reduction
Lilly’s Zepbound tops Novo Nordisk’s Wegovy for weight loss in head-to-head trial
Companies competing for leadership in fast-growing market where supply continues to be an issue
Medicines sector puts Ireland Inc on notice
Brussels rather than the Trump White House is seen by industry as the more immediate threat to its wellbeing
Ireland should oppose EU proposals on regulatory protection for medicines
European Commission has proposed reducing the period of regulatory data protection from eight years to six years
Robert Kennedy jnr: Pharma investors brace for impact
Vaccine makers and companies manufacturing breakthrough obesity drugs saw share prices fall on nomination
Covid factor chills profits at pharma group West
US packaging giant backing huge demand for injectable obesity drugs to fill the gap left by falling demand for Covid vaccines
Pharma packaging group West announces 330 jobs for Dublin
Announcement is first major investment by a US multinational following Trump victory in presidential election
Weight-loss drugs show promise in tackling opioid and alcohol abuse
Academic notes while Ozempic might prevent overdoses, weight loss drug may not actually reduce or end substance use
Europe’s Stoxx 600 index posts biggest one-day gain since November
Strong day for banking stocks lifts Irish market, while Airbnb and Puma fall after weak outlook statements
Obesity drugmaker Novo Nordisk misses profit forecast
Danish company employs about 450 people in Ireland
Novo Nordisk drops Dublin factory plan
Seen & Heard: Inheritance tax reduction, Press Up stake and Spar sale
US shares advance as markets eye Apple results
Iseq index outperforms its peers, adding 1.5% after positive updates from Smurfit Kappa and Glenveagh Homes
EU rules drive pharma backers to the US, says IDA Ireland chief
Europe’s regulations have become ‘too burdensome’ and could hinder innovation, argues Michael Lohan
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
The GlossOpens in new window
Read the digital edition of The Gloss magazine now
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices